Dr. Mary Beth Westerman, speaks on notable advances that she has see in bladder cancer throughout her career. Dr. Westerman speaks on what clinicians can do to improve pre-operative counseling for female patients with bladder cancer. Dr. Mary Beth Westerman provides insight on some of the main challenges in treating women with bladder cancer. A review of a series of articles published by Urology on diversity, equity, and inclusion findings in prostate cancer care. Delays in the initiation of intensity-modulated radiotherapy may contribute to known differences in cancer outcomes. Annual screening compared with “some screening” was associated with a significant reduction of PCSM risk for Black men. Researchers evaluate the frequency of germline DDRg mutations in metastatic prostate cancer patients of different ancestries. The South Texas region, with a predominantly Latinx population, has a very high incidence of renal cell carcinoma. This study offers a realist approach to rethinking and operationalizing the WHO 2017 guide to cancer early diagnosis. At present, there are few studies on renal pelvic transitional cell carcinoma (RPTCC) in elderly patients in the literature. The study examines a cohort of prostate cancer patients who underwent external beam radiation therapy from 1990 to 2017. Sexual and gender minority persons face disproportionate risks for and rates of many cancers, including prostate cancer. Prior to this, no national curative treatment for recurrent prostate cancer following radiation therapy existed in Denmark. The propensity score matching investigated the medical expenditure of RP and IMRT in elderly patients with high-risk LPC. Minorities experience disparities in shared decision-making when it comes to discussions on the advantages of PSA testing. Researchers co-created the video with African and African-Caribbean men and promoted it throughout Black History Month. Analysis shows that radiation therapy seems to work better for Black men with prostate cancer than for their White peers. Researchers evaluate PSA screening frequency and the effect of different screening intensities on prostate cancer diagnoses. Researchers observed treatment for MIBC in academic facilities didn’t mitigate poorer outcomes for disadvantaged ... For prostate cancer patients, variables like definitive treatment and time to treatment initiation are inferior at HSDPs.